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ACCEPTED MANUSCRIPTABSTRACT  
 
The results reported here indicate that the electron density obtained from a QTAIM analysis is 
an excellent descriptor of molecular interactions that stabilize and destabilize the formation of 
the ligand-receptor (L-R) complex. The study was conducted on a series of 25 compounds 
that have inhibitory effects on DHFR. Besides the synthesis and bioassays performed for 
some of these compounds, various types of molecular a culations were performed. Thus, we 
performed MD simulations, computations at different levels of theory (ab initio and DFT) 
using reduced models and a QTAIM study on the different complexes. 
The resulting model has allowed us to differentiate not only highly active compounds with 
respect to compounds weakly active, but also among c mpounds that have similar affinities in 
this series. The model also showed a high degree of predictability which allows predicting the 
affinity of non-synthesized compounds. Very important additional information can be 
obtained through this type of study, it is possible to visualize which amino acids are involved 
in the interactions determining the different affinities of the ligands. 
 













ACCEPTED MANUSCRIPTINTRODUCTION  
 
In general, majority of docking algorithms are able to predict the bind correctly, with 
accuracy of ~ 2 Å root-mean-square deviation (RMSD) to that of observed in the crystal 
structure (of course depending of the structural characteristics of both the ligand and the 
binding pocket). The challenge is in scoring these L-R bindings; an ideal scoring function 
should be able to reproduce binding energy and to rank the ligands according to their binding 
affinities. However, the majority of scoring functions, bundled with docking packages, often 
perform a very poor reproduction of the binding affinity; hence, the use of them is limited to 
screening of databases of a large number of ligands. 
In order to predict binding affinity of small molecule inhibitors, a variety of post-docking 
methods have been established. These methods range from simple consensus scoring to free 
energy perturbation (FEP) [1-4] among others. Undoubtedly, the post-docking methods can 
improve significantly the prediction of the energies of L-R binding, however they are still far 
from being able to predict with a high degree of accuracy the differences in L-R affinities for 
those ligands having similar binding energies. The situation is even more complex when we 
are in front of compounds with structural differencs. In such cases, most of the times one 
must accept only if we can differentiate between very active compounds from compounds 
with low affinity for the receptor (very poor activity). It is clear that any progress or 
improvement that we can find to enhance these post-d cking methods is of paramount 
importance for the structure based drug design and they are very welcome. 
In a recent paper we attempted to find a correlation hat would allow us to differentiate 
between DHFR inhibitors with similar affinities, but we had no success [5]. In fact, we were 
only able to differentiate between highly active compounds of those who had very poor 
activity, but we were not able to differentiate betw en compounds with similar affinities. In 
that paper we also showed that if one has a good gemetry, the QTAIM study provides an 
important insight into the molecular interactions between ligand and receptor. In this new 
work, we used the electron density obtained from QTAIM analysis as a descriptor of the 
molecular interactions of the L-R complex, which has allowed us to discriminate very well 
between compounds with similar binding affinities. 
Dihydrofolate reductase (DHFR) is an excellent molecu ar target for this study because it has 
been and is currently studied by using different molecular modeling techniques [6-9]. 
Kerrigan et al. have reported an interesting review about recent progress in molecular 
dynamics simulations of DHFR [10] and they conclude that “molecular mechanics 












ACCEPTED MANUSCRIPTDHFR. However, DHFR continues to be a challenge for free energy estimation methods and 
caution is recommended when interpreting these results”. 
It should be noted that there are very few simulations specifically focused in the molecular 
interactions involved in the formation of the L-R complexes. Thus, interesting details about 
the intricacies of molecular interactions of DHFR interacting with its inhibitors remain 
unknown. Recently, we reported some molecular modeling studies using reduced models for 
the binding pockets [5, 11-15]. This approach allows performing more accurate quantum 
mechanical calculations, as well as to obtain a detailed electronic analysis by using the 
method of Quantum Theory of Atoms in Molecules (QTAIM). 
The main objective of this work is to find a way tha  allows us to differentiate between 
ligands possessing similar affinities for the DHFR. To achieve this goal, different calculations 
techniques have been used either alone or in combination in order to find a molecular 
descriptor that allows getting such differentiation. Thus, the present study was carried out at 
different stages. In the first step, seven new compounds were synthesized and then they were 
evaluated for their inhibitory activities against human DHFR. These results were added to 
thirteen compounds reported by Gangjee et al. (1-13) [16], two compounds reported in our 
earlier work (14a and 15a) [5] and two new compounds (14e and 15f) recently reported in 
reference [17] in order to have a more complete and representative number of compounds (25 
molecules in the complete series (Figure 1 and Table 1)). In the next step, we performed MD 
simulations, QM calculations (using different levels of theory) and QTAIM analysis with the 
aim to obtain a correlation which allows the discrimination between compounds possessing 

















































Table 1. Structural features and IC50 values of compounds type 14 and 15. 





65.98 ± 6.5 
14c 
 
63.05 ± 6.3 
14d 
 
52.89 ± 5.2 
14e* 
 





27.87 ± 2.7 
15c 
 
43.84 ± 4.3 
15d 
 
77.09 ± 7.7 
15e 
 
20.81 ± 2.0 
15f* 
 







































3 Ar = C6H5 (18 µM) * 
4 Ar = 2,6-diMeC6H3 (32 µM) * 
5 Ar = 2-naphthyl (6 µM) * 
6 Ar = 3,4-diClC6H3 (2.8 µM) * 
7 Ar = 1-naphthyl (2.9 µM) * 
8 Ar = 4-NO2C6H4 (5.8 µM) * 
9 Ar = 4-BrC6H4 (2.7 µM) * 
10 Ar = 2,4-diClC6H3 (1.4 µM) * 
11 Ar = 4-OMeC6H4 (2.9 µM) * 
12 Ar = 2,5-diOMeC6H3 (5.8 µM) *  
13 Ar = 8-quinoline (1.8 µM) *  
1   R = Et (0.066 µM) * 
2   R = Me (0.21 µM) *  
















14a (68.01 µM) ** 
 
15a (54.45 µM) ** 
 












ACCEPTED MANUSCRIPT*Compounds reported in reference 17 
 
METHODS OF CALCULATIONS 
The results of this work have been compared with those recently reported in the reference 5; 
therefore all calculations and molecular simulations have been performed using the same 
techniques previously used. 
 
MD simulations 
The starting structure of human DHFR was obtained from Protein Data Bank of Brookhaven 
National Laboratory (PDB entry code 2W3M) and the topologies of the ligands were built 
using the MKTOP program [18]. MD simulations for each L-R complex have been carried 
out using the GROMACS 4.5.5 simulation package [19, 20]. For these simulations, the 
OPLS-AA force field [21-26] and the rigid SPC water model [27, 28] in a cubic box with 
periodic boundary conditions were employed. The box size was 7.437 x 7.437 x 7.437 nm and 
the total number of water molecules was approximately 14,500 for each simulation. Besides, 
three Na+ ions were added to the systems by replacing water molecules in random positions, 
thus making the whole system neutral. 
A steepest-descent algorithm for 1,000 steps was used, in order to minimize the energy of 
each system. Next, the complexes were equilibrated during 100 ps in NVT and NPT 
ensembles to stabilize the temperature and the pressure of each system, respectively. Then a 5 
ns MD simulation was performed for each complex. The time step was 0.002 ps and the 
temperature was maintained constant at 310 K with the V-rescale algorithm [29]. Long range 
interactions were treated by the Particle Mesh Ewald (PME) method [30, 31] with a 1 nm 
cutoff and a Fourier spacing of 0.12 nm. The compressibility was 4.8 x 10-5 bar-1. 
The Linear Interaction Energy (LIE) method was used to calculate L-R binding free energy 
[32, 33]. The following equation was used for such calculations: 
 
∆	 = 〈	〉	 − 〈	〉 + 	〈 〉	 − 〈 〉												(1) 
 
where α and β parameters are dispersion and electrostatic adjustble energy scale factors [34]. 
Their values (0.181 and 0.5, respectively) were previously reported by Marelius et al., who 
adjusted them for DHFR from experimental parameters [35]. The 〈	〉 and 〈V#-%&# 〉 terms 
denote MD energy averages of the nonbonded van der Waals and electrostatic interactions 















MM-GBSA Free Energy Decomposition 
The MM-GBSA free energy decomposition was carried out in order to evaluate which amino 
acids were interacting with the ligand. This calculation allows decomposing the interaction 
energies to each residue considering molecular mechani s and solvation energies [36-40]. 
Four energy terms are considered for each inhibitor-residue pair: van der Waals contribution 
(∆'	), electrostatic contribution (∆'), polar desolvation term (∆()), and nonpolar 
desolvation term (∆*+). These terms can be summarized as the following equation: 
  
∆,-	 = ∆'	 + ∆' + ∆() + ∆*+																																			(2) 
 
For these calculations, the mm_pbsa program in AMBER12 [41] has been employed and 
snapshots were taken at 10 ps time intervals from the corresponding last 1,000 ps MD 
trajectories, while the explicit water molecules were removed from the snapshots. 
 
Constructing the reduced models for the binding site 
The use of model systems to calculate and simulate mol cular interactions (MI) is necessary 
since the inhibitors interacting at the active site of DHFR constitute a molecular system too 
large for accurate quantum mechanics molecular orbital calculations and the number of 
ligands to be screened is large as well. 
Since we are interested in comparing the results obtained in this work with those reported in 
our previous work, we use the same reduced system that was used in that study [5]. This 
reduced model is composed by 23 amino acids: Ile7, Val8, Ala9, Leu22, Trp24, Glu30, 
Phe31, Tyr33, Phe34, Gln35, Met52, Thr56, Ser59, Ile60, Pro61, Asn64, Leu67, Lys68, 
Arg70, Val115, Tyr121, Val135 and Thr136. In addition all water molecules within a 5 Å 
radius from the ligand were also included in the reduced model. 
To be sure that the different amino acids that stabilize and destabilize the complex formation 
have been included in the reduced system, we performed an MM-GBSA free energy 
decomposition analysis for the different complexes under study. The information obtained 
from these calculations is very important for quantit tive analysis and is highly useful for the 
understanding of the binding mechanism. Figure 1S in upplementary Material displays the 
spectra obtained for the most representative compounds reported here. A surface of the 




















First, the twenty-three residues included in our reduced model and the ligand were calculated 
at the PM6 [42] level of theory, using the MOPAC2009 program [43]. The ligand and the 
torsional angles, bond angles and bond lengths of the side chains of the amino acids were 
optimized, while the atoms of the backbone were frozen during calculations. For these 
optimizations, four different starting geometries from MD simulations were taken into 
account: the global minimum and three local minima, obtained from the potential energy 
calculations. This step is important because in this way, a more representative sample of the 
spatial arrangements of the complexes was evaluated. Then, we have performed single point 
calculations of optimized geometries at RHF/6-31G(d) and PBE1PBE/6-31G(d) levels of 
theory, using Gaussian 09 program [44]. 
The binding energy (BE) of each complex L-R was calcul ted employing the following 
equation: 
 
/'01 =	'2345 −	('2345 +	')																																																(3) 
 
where /'01 is the binding energy, E8-9:;< is the complex energy, '2345 is the energy of the 















Topological Analysis of the Electron Charge Density Distribution 
The reduced models constructed for the studied complexes were then submitted to topological 
analysis of the charge density (ρ(r)). QTAIM calculations were performed over Kohn-Sham 
DFT wave functions employing the hybrid PBE functional and 6-31G(d) as basis set. 
The terminology of QTAIM was extensively reviewed in the standard literature [45]. Next, 
we briefly summarize some basic concepts that are needed for the discussion of results. From 
the QTAIM point of view, two interacting atoms share three topological elements related to 
each other, a point, a line and a surface. The first element is the bond critical point (BCP), 
namely the critical point in ρ(r) topology that is found between any two interacting nuclei. 
From each BCP, two unique trajectories of gradient vectors of electronic density, ∇ρ(r), 
originate at that point and terminate at each of the neighboring nuclei. These trajectories 
define a line along which ρ(r) is a maximum with respect to any neighboring line. This line, 
that constitutes the second element, is the bond path, BP. Additionally, the set of trajectories 
that terminate at a BCP define the interatomic surface (IAS) that separates the atomic basins 
of the neighboring atoms [45]. 
The determination of all the intermolecular BCPs and the corresponding BPs were performed 
with Multiwfn [46] and AIMPAC [47] software. The molecular graphs were depicted with 
Pymol [48]. 
In this paper, QTAIM calculations were performed in order to determine the ρ(r) values at the 
BCPs established between each atom (belonging to the backbone or the side chain) of the 
amino acids of the receptor and each atom of the ligand. In order to obtain the total ρ(r) value 
of the interaction between a particular residue and the inhibitor, we performed the sum of the 




where =5 is the ρ(r) value for the total interaction with a particular residue and 
=-?@-	5 represents the ρ(r) value of each interaction (BCP) between the atoms f the 
ligand and the corresponding residue. 
 
Multivariable Linear Regression  
A data set of 25 compounds with known DHFR inhibition activity was utilized to perform a 
Multivariable Linear Regression (MLR) analysis with t e aim to establish a mathematical 












ACCEPTED MANUSCRIPTIn this analysis, we considered each ρ(r) value of each interaction as a molecular descriptor in 
order to use them as independent variables while the biological activity (expressed as –log 
IC50) was utilized as the dependent variable. A total of 23 interactions, which belong to the 
reduced model, were used as molecular descriptors. The values of the biological activity as 
well as the numbering of the compounds included in the data set are given in Table 1. 
The mathematical models were developed using a subset of 22 compounds (calibration set) 
from the full data set. Then, the optimal model was v lidated through a test set containing 3 
compounds which do not form part of the calibration set. The elements of each set (calibration 
and test set) were selected in such a way that they s are similar structural characteristics and 
the experimental data of the test set represent of the whole span. Thus, the compounds 7, 14c 
and 15c were selected as test set.  
The optimal model was developed by performing an exhaustive search selecting the best 
linear regressions (minimum standard deviation (S))from each combination from 1 to 20 
molecular descriptors. The quality of the models is uggested for the calculated coefficients of 
determination (R2) and the standard deviations (S). All the MLR calculations were carried out 
using the MATLAB 7.0 software [49]. 
 
EXPERIMENTAL SECTION 
General Experimental Section 
Solvents and Reagents 
Reagents and solvents used were purchased from commercial suppliers and use without 
further purification procedures. 
Chromatography 
Thin layer chromatography (TLC) was used to monitorize the reaction progress and product 
purity, it was performed on Merck Kieselgel 60 F254 aluminium precoated plates, and spots 
visualized with ultra-violet irradiation. 
Melting Points 
Melting points were recorded on a Digital Melting Point Apparatus, model IA9300 series, 
Barnstead Electrothermal nd are uncorrected. 
NMR Spectroscopy 
1D (1H, 13C, DEPT) and 2D (COSY, HSQC and HMBC) NMR spectra were recorded on 
Brucker Advance 400 spectrometer. Chemical shifts (δH) are quoted in parts per million 
(ppm) downfield of tetramethylsilane, and residual proton of the solvent (δH ((CH3)2SO) = 
2.49 ppm) used as internal reference. Coupling constants (J) are given in Hertz (Hz), and 












ACCEPTED MANUSCRIPTNMR spectra are reported as follows: δ/ppm (multiplicity, number of protons, coupling 
constants J/Hz).  
Mass Spectrometry 
Low resolution mass spectrometry by electron impact was recorded on a Hewlett Packard HP 
Engine-5989 spectrometer (equipped with a direct inlet probe) at 70 eV. High Resolution 
Mass Spectra by electron impact were recorded on a Micromass Auto Spec-Ultima, magnetic 
sector mass spectrometer at 70 eV. 
 
General Procedure for the synthesis of imine derivatives (14b-d): To a solution of 
triaminepyrimidine 1 (1 mmol) in 15 mL of methanol, 1 mmol of appropriate 
arylbenzaldehyde was added, and this solution was stirred overnight at room temperature. The 
solid formed was filtered off, washed with fresh methanol and dried at 50 ºC, if necessary it 






(14b). 80% yield; Yellow solid; pf 168-169 ºC; Rf 0.38 (Chloroform); IR (ν cm
-1): 3330, 
3226, 2923, 1639, 1603, 1560; 1H NMR (DMSO-d6): δ 2.37 (s, 3H), 3.94 (s, 3H), 6.56 (s, 
2H), 6.99 (t, 1H, 8 Hz), 7.27 – 7.32 (m, 4H), 7.83 – 7.87 (m, 4H),  8.66 (s, 1H), 9.01 (s, 1H). 
13C NMR (DMSO-d6): δ 21.0, 53.0, 102.7, 120.7, 121.7, 127.6, 128.4, 129.2, 135.2, 139.7, 
140.0, 153.7, 158.2, 159.6, 161.2. MS (m/z, %) (assignation, abundance %): 333 (M+, 68.2), 
332 (M-1, 48.5), 331 (M-2, 100), 302 (M-31, 10.1), 242 (M-91, 89.9), 215 (M-118, 9.4), 77 
(C6H5
+, 24.7). Calculated HRMS for C19H19N5O: 333.1590; found: 333.1578. 
6-methoxy-N4-phenyl-N5-[(E)-pyridin-4-ylmethylidene]pyrimidine-2,4,5-triamine  (14c). 
85% yield; Yellow solid; pf 208-210 ºC; Rf 0.09 (Chloroform); IR (ν cm
-1): 3431, 3335, 3215, 
1653, 1607, 1566, 1543; 1H NMR (DMSO-d6): δ 3.97 (s, 3H), 6.78 (s, 2H), 7.03 (t, 1H, 8 Hz), 
7.32 (t, 2H, 8 Hz), 7.86 – 7.91 (m, 4H), 8.66 (s, 2H), 8.77 (s, 1H), 9.01 (s, 1H). 13C NMR 
(DMSO-d6): δ 53.1, 102.6, 120.6, 121.3, 122.1, 128.3, 139.7, 144.5, 149.7, 150.0, 158.8, 












ACCEPTED MANUSCRIPT(M-78, 100), 215 (M-105, 3.6), 77 (C6H5
+, 6.4). Calculated HRMS for C17H16N6O: 320.1386; 
found: 320.1385. 
2-[(E)-{[2-amino-4-methoxy-6-(phenylamino)pyrimidin-5-yl]imino}methyl]phenol (14d). 
78% yield; Yellow solid; pf 178-180 ºC; Rf  0.29 (Chloroform); IR (ν cm
-1): 3462, 3345, 
3229, 1632,1601, 1555, 1120, 1082; 1H NMR (DMSO-d6): δ 3.90 (s, 3H), 6.52 (s, 2H), 6.91 – 
6.99 (m, 3H), 7.26 – 7.33 (m, 3H), 7.70 – 7.76 (m, 3H), 8.44 (s, 1H), 9.09 (s, 1H), 11.84 (s, 
1H). 13C NMR (DMSO-d6): δ 52.9, 103.2, 115.9, 118.7, 119.9, 121.4, 121.5, 128.0, 129.5, 
131.2, 140.0, 156.7, 157.7, 158.3, 159.2, 160.6. MS (m/z, %) (assignation, abundance %): 335 
(M+, 54.8), 334 (M-1, 16.2), 242 (M-93, 100), 215 (M-120, 8.8), 77 (C6H5
+, 11.9). Calculated 
HRMS for C18H17N5O2: 335.1382; found: 335.1380. 
 
Procedure for the one-pot synthesis of guanine derivatives (15b-e): To a solution of 
triaminepyrimidine 1 (1 mmol) in 15 mL of methanol, 1 mmol of appropriate 
arylbenzaldehyde was added, and this solution was stirred overnight at room temperature. The 
solid formed was filtered off, washed with fresh methanol and used directly without further 
purification with 1 mmol of iodine in 20 mL of AcOEt; the reaction mixture was stirred for 24 
h at room temperature. The solid formed is filtered off and washed with a solution of 
NaHCO3, then with a solution of sodium thiosulfate and, drie  in an oven at 100 
oC) (see 
Scheme 1).  
2-amino-8-(4-methylphenyl)-9-phenyl-1,9-dihydro-6H-purin-6-one (15b). 60% global 
yield; Beige solid; pf > 300 °C; Rf  0.79 (CHCl3/CH3OH, 9:1); IR (ν cm
-1): 3420, 3183, 1695, 
1647; 1H NMR (DMSO-d6): δ 2.25 (s, 3H), 6.54 (s, 2H), 7.08 (d, 2H, 8 Hz), 7.24 (d, 2H, 8 
Hz), 7.33 (m, 2H, broad band), 7.48 (m, 3H, broad band), 10.69 (s, 1H). 13C NMR (DMSO-
d6): δ 20.7, 116.3, 127.2, 128.0, 128.2, 128.6, 128.7, 129.3, 135.6, 138.2, 145.2, 153.7, 153.8, 
156.8. MS (m/z,%) (assignation, abundance %): 317 (M+, 100), 316 (M-1, 37), 300 (M-17, 6), 
275 (M-42, 6), 194 (M-123, 19), 77 (C6H5
+, 12). Calculated HRMS for C18H15N5O: 317.1277; 
found: 317.1269. 
2-amino-9-phenyl-8-[4-(propan-2-yl)phenyl]-1,9-dihydro-6H-purin-6-one (15c). 59% 
global yield; Beige solid; pf > 300 °C; Rf  0.80 (CHCl3/CH3OH, 9:1); IR (ν cm
-1): 3424, 3308, 
3184, 1694, 1645, 1599, 1368; 1H NMR (DMSO-d6): δ 1.15 (d, 6H, 8 Hz), 2.83 (sp, 1H, 8 
Hz), 6.53 (s, 2H), 7.15 (d, 2H, 8 Hz), 7.29 (d, 2H, 8 Hz), 7.36 (m, 2H, broad band), 7.50 (m, 
3H, broad band), 10.69 (s, 1H). 13C NMR (DMSO-d6): δ 23.5, 33.0, 116.3, 126.0, 127.5, 
127.9, 128.2, 128.7, 129.4, 135.6, 145.1, 148.9, 153.7, 153.8, 156.8. MS (m/z,%) (assignation, 
abundance %): 345 (M+, 100), 344 (M-1, 20), 330 (M-15, 55), 222 (M-123, 7) 77 (C6H5
+, 












ACCEPTED MANUSCRIPT2-amino-8-(2-hydroxyphenyl)-9-phenyl-1,9-dihydro-6H-purin-6-one (15d). 66% global 
yield; Beige solid; pf > 300 °C; Rf  0.79 (CHCl3/CH3OH, 9:1); IR (ν cm
-1): 3424, 3308, 3161, 
1699, 1651, 1211; 1H NMR (DMSO-d6): δ 6.58 (t, 1H, 8 Hz), 6.79 (d, 1H, 8 Hz), 6.84 (s, 2H), 
6.90 (d, 1H, 8 Hz), 7.17 (t, 1H, 8 Hz), 7.43 – 7.45 (m, 3H), 11.45 (s, 1H)12.07 (s, 1H). 13C 
NMR (DMSO-d6): δ 113.9, 116.8, 118.1, 127.2, 128.1, 129.1, 129.6, 130.4, 135.7, 144.1, 
153.1, 154.6, 156.5, 157.3. MS (m/z, %) (assignation, abundance %): 319 (M+, 100), 318 (M-
1, 75), 302 (M-17, 20), 301 (M-18, 10), 276 (M-43, 5) 196 (M-123, 13), 77 (C6H5
+, 16), 43 
(M-278, 6). Calculated HRMS for C17H13N5O2: 319.1069; found: 319.1073. 
2-amino-8-(1,3-benzodioxol-5-yl)-9-phenyl-1,9-dihydro-6H-purin-6-one (15e). 52% global 
yield; Beige solid; pf > 300 °C; Rf 0.82 (CHCl3/CH3OH, 9:1); IR (ν cm
-1): 3422, 3186, 1694, 
1645, 1232, 1032; 1H NMR (DMSO-d6): δ 6.01 (s, 2H), 6.49 (s, 2H), 6.82 – 6.86 (m, 3H, 
broad band), 7.35 (s, 1H, broad band), 7.51 (s, 4H, broad band),10.66 (s, 1H). 13C NMR 
(DMSO-d6): δ 116.5, 122.1, 128.0, 128.8, 129.1, 129.4, 129.8, 131.1, 135.2, 144.0, 153.8, 
153.9, 156.7. MS (m/z,%) (assignation, abundance %): 347 (M+, 100), 346 (M-1, 45), 304 (M-
43, 4), 224 (M-123, 13), 77 (C6H5




To avoid including experimental errors in the correlation, we used exactly the same bioassay 
as those used in reference [5]. The assay is based on the ability of DHFR to catalyze the 
NADPH-dependent reduction of dihydrofolic acid to tetrahydrofolic acid. The rate of 
NADPH consumption in the presence of the compound under investigation is monitored by 
the decrease in absorbance at 340 nm [50-55] every 15 seconds, during 2.5 minutes. Reactions 
were performed in a solution containing saturating concentrations of cofactor (80 µM 
NADPH) and substrate (50 µM dihydrofolate), 15 µL of enzyme solution, 50 mM Tris−HCl, 
0.001 M 2-mercaptoethanol, and 0.001 M EDTA at pH 7.4 and 30 °C. The enzyme was 
purchased from Sigma-Aldrich Co. (St. Louis, MO). In order to determine IC50 values, five 
different concentrations of compounds as inhibitors were tested (each assay was made by 
triplicate) and percent inhibition graphs were drawn by using statistical packing program on a 
computer. 
 
RESULTS AND DISCUSSION 
We recently reported two new DHFR inhibitors: compounds 14a and 15a [5]. In order to have 
a more extensive series and based on these two structures, we decide to synthesize seven 
novel derivatives from 2,4,5-triamino-6-methoxypyrimidine with diverse aryl aldehydes to 












ACCEPTED MANUSCRIPTrelated to compound 15a), which were prepared in a two-step one-pot procedure (Scheme 1 
and Table 1). 
In the next step we tested the inhibitory effect of these compounds; such results are 
summarized in Table 1. As we can see from Table 1 some of these compounds displayed a 
relatively significant activity, such as compound 15b which shows inhibitory effect at 
concentrations of 27.87µM. 
As it was stated above the main objective of this work is to obtain a correlation between the 
binding energies of these compounds and their respective IC50. Therefore MD simulations and 
quantum mechanical calculations were performed for all the L-R complexes. To try to use a 
sample as representative as possible of different types of ligands, we also include in this 
analysis the sixteen compounds reported in our previous work [5], thus forming a complete 
set of 25 compounds (Figure 1). 
As we expected the general results obtained from MD simulations were very similar to those 
previously reported for compounds 14a and 15a [5]. A highly conserved glutamic acid 
(Glu30) is functioning as an anchoring point. In the present study, all the simulated 
compounds were docked into the receptor with the N1 and 2-amino group near to Glu30. 
After 5 ns of MD simulations, the ligands moved slightly but in a different form compared 
with the initial position. However, the strong interaction with Glu30 was maintained for all 
the complexes. Other important MI stabilizing the different complexes are: π···π stacking 
interactions with Phe31 and Phe34, and hydrophobic interactions with Ile7 and Val115. 
Next, the BE obtained for the different complexes were evaluated. From the BE obtained 
from our MD simulations, a very good binder can be differentiated from a very weak binder (-
11.85 kcal/mol for MTX vs. -6.74 and -3.61 kcal/mol for compounds 14b and 15c, 
respectively) but ligands with similar binding affinit es cannot be easily differentiated. In 
function of the IC50 values we were expecting exactly the opposite values for compounds 14b 
and 15c. Similar to these unexpected results, there are oth rs that might be observed in Table 
1S in Supplementary Material. In addition, it is important to note that the value of R2 obtained 
for this correlation is very low (0.49) (Figure 3). This result clearly indicates that by using this 
approximation is not possible to discriminate between compounds with similar binding 
affinities; in addition the low correlation obtained indicates a very poor predictive power of 
the method. This result was not surprising since we obtained similar results in our previous 
work using this approach [5]. Considering that MD simulations might neglect or poorly 
approximate terms that are playing determinant roles (such as lone pair directionality in 
hydrogen bonds, explicit π···π stacking polarization effects, hydrogen bonding networks, 
induced fit, and conformational entropy), we cannot expect to detect clear differences 

















In the next step of our study, reduced model system were optimized using combined 
semiempirical, ab initio and DFT calculations. To perform these calculations, reduced system 
models were employed whose design is explained in the calculation methods section. PM6 
optimizations were performed considering all receptor amino acids that might interact after 
initial positioning of the ligands against Glu30 residue. Next, RHF/6-31G(d) and DFT 
(PBE1PBE/6-31G(d)) single point calculations were carried out for each complex optimized 
from PM6 computations. 
It is important to note that the L-R interaction is a dynamic process and therefore in order to 
have a more accurate description of such situation, four different snapshots for each complex 
were considered. This resulted in different energy values and such variation can be observed 
in the error bars which are shown in Figures 4, 5 and 6. Once the BE of the different 
complexes were obtained from the theoretical calcultions, the different correlations between 
these theoretical calculations and our experimental data (Table 1) were calculated. The Figure 
4 shows that semi-empirical calculations (PM6) gave  correlation between the BE and the 
inhibitory activity with an R2 value of 0.49, which does not improve those results obtained 
with the LIE method (Figure 3). However, the result obtained from RHF/6-31G(d) (Figure 5) 
and PBE1PBE/6-31G(d) (Figure 6) were significantly better with R2 values of 0.77 and 0.76, 
respectively. Nevertheless it is important to note that not only the value of R2 is important in a 
correlation but also how the distribution of the various points along the line is. Regarding 
Figures 5 and 6 it is evident that the different points are clustered into two well-defined 












ACCEPTED MANUSCRIPTa very active compound with respect to a compound with low affinity, however there is room 
for doubt whether it is possible to distinguish betw en two compounds having similar 
affinities. To corroborate this assumption we removed the three classical type inhibitors 
(MTX , compounds 1 and 2) from the series and a new correlation was obtained with this new 
series. Such as we expected the new correlations gave very low R2 values (0.64 and 0.61 for 
ab initio and DFT calculations, respectively). These results show the severe limitations of 
these approaches in order to correctly predict the in ibitory activity between compounds with 
similar affinities. This result was somewhat disappointing for us so we seek a new parameter 
or kind of molecular descriptor that might be able to predict the inhibitory activity between 
























We recently reported that the information about theel ctronic density obtained from a 
QTAIM analysis is useful to describe the molecular interactions that stabilize and destabilize 
the different complexes L-R [13-15]. Specifically in our previous work reported for DHFR 
inhibitors, the QTAIM analysis gave very interesting results when it was applied to this 
molecular target [5]. Therefore in the next stage of our study we performed a QTAIM analysis 
of all the complexes in order to find a new descripto  for this series. 
 
QTAIM Analysis 
The Figure 7 shows the sum of the ρ(r) values corresponding to the interactions of the Pyr 
system and C6 and/or N7 side chains obtained for the different inhibitors analyzed here. The 
different moieties of each type of inhibitor are showed in Figure 8. The sum of the ρ(r) values 
for all the interactions of one part of the inhibitor (i.e., the Pyr ring system and the C6-side 
chain) provides a measure of the anchoring strength of such moiety of the inhibitor to the 
binding pocket. Figure 7 clearly shows that the classical inhibitors (MTX, 1  and 2) bind to the 
enzyme with similar strength through both parts of the molecule, the Pyr system and the C6-
side chain. Non-classical inhibitors reported by Gangjee et al. (compounds 3-13) bind their 
Pyr portions with similar strength to that of the classical inhibitors, but the anchoring through 
the C6-side chain is much weaker in these inhibitors with respect to the classical ones. 
Regarding the inhibitors reported here (compounds 14b-e and 15b-f), on average, these 
compounds are more weakly bonded to the binding pocket than the rest of the inhibitors. 
Analyzing the anchoring strength of each part of these compounds to the binding pocket, it 












ACCEPTED MANUSCRIPTthe C6- and N7-side chains. It can also be observed that the equivalent Pyr ring system is 
more weakly H-bonded to the active site in these new compounds than in the rest of the 
inhibitors. In contrast, the C6- and N7-side chain from compounds 14a-e and 15a-f are on 

























The electronic density ρ(r)  as a molecular descriptor for the L-R affinity 
The QTAIM study allows not only analyzing quantitatively each interaction but also getting a 
correlation using the calculated ρ(r) values and the IC50 data obtained in our laboratory. For 
this purpose, we have considered the ρ(r) value obtained from the QTAIM analysis as a 
molecular descriptor in order to use them as independent variables in the multivariable lineal 
regression analysis (for details about this analysis see the method section).  
Of the 25 total compounds under study, 22 were used for the construction and calibration of 
the model, while the remaining three (compounds 7, 14c and 15c) were left to test it. 
Therefore it should be noted that a model of up to 20 amino acids was obtained. Thus, we 
obtained the corresponding correlations using different number of amino acids. In the Figure 
9, it can be appreciated that the utilization of 7 amino acids is enough to get a very good value 
of R2 and increasing the number of them does not significantly improved the correlation. In 
the Table 2, the main results obtained for models using different numbers of amino acids 
(from 3 to 8) are summarized. Importantly, all the models showing significant correlations 
maintain the same four amino acids (Val8, Ala9, Leu67 and Arg70), indicating that they are 
essential to discriminate the L-R affinity among these compounds. The model possessing only 
three amino acids maintains only two of these amino acids and has a significantly lower value 
of R2 (see the first column of Table 2). Although the model with eight amino acids has a high 
value of R2, however its power of prediction is lower with resp ct to the model of seven 
amino acids (see the third column in Table 2). These results indicate that the model 
considering seven amino acids would be the most robust in order to analyze this series 

























compounds Excluding MTX, 1 y 2 
R2 (*) S(*) R2val(**)  R2 (*) S(*) R2val(**)  
3 Leu67, Arg70 and Tyr121 0.80 0.48 0.98 0.66 0.40 0.93 
4 Val8, Ala9, Leu67 and Arg70 0.86 0.42 0.99 0.75 0.35 0.97 
5 Val8, Ala9, Asn64, Leu67 and Arg70 0.90 0.37 0.99 0.79 0.34 0.97 
6 Val8, Ala9, Asn64, Leu67, Arg70 and Thr136 0.92 0.33 0.99 0.88 0.26 0.98 
7 Val8, Ala9, Asn64, Leu67, Arg70, Val115 and Thr136 0.93 0.32 0.99 0.90 0.25 0.99 
8 Val8, Ala9, Thr56, Asn64, Leu67, Arg70, Val115 and Thr136 0.94 0.30 0.94 0.91 0.25 0.96 
 
(*) Calculated R2 y S values from the corresponding model. 
(**)  Calculated R2 value for the 3 compounds (7, 14c and 15c) used to validate the model. 
 
The mathematical model of 7 amino acids was tested using the three compounds which do not 
form part of the initial statistical analysis. As can be seen in Table 3, the predicted activities of 
these compounds do not differ from the experimental results, showing the high predictive 
power of the developed model. The residues included in this model are: Val8, Ala9, Asn64, 
Leu67, Arg70, Val115 and Thr136. The first two ones interact with the main ring of the 
ligand (Pyr ring) through hydrogen bonds with the atoms of their backbones. Asn64 presents 
polar interactions with different groups located on the phenyl ring. In the case of Leu67, this 
residue displays hydrophobic interactions with the p nyl ring and different non polar groups 
located on it. It is important to note that the interaction of Arg70 with the ligands allows the 
differentiation between classical and non-classical compounds. This residue is able to form a 
salting bridge with the α-carboxilate group of classical inhibitors, which is a very strong 
interaction. In a minor degree, Arg70 presents MI with polar groups of the non-classical 
ligands. Val115 and Thr136 can establish hydrogen bo d interactions with amino groups 
located in the Pyr ring. Some residues like Glu30, Phe31 and Phe34, which produce important 












ACCEPTED MANUSCRIPTobserved in these residues are present in a similar way in all complexes and, therefore, they 
do not allow us to differentiate the ligands in terms of their activities within the series. Most 
of the interactions previously described might be well appreciated in Figure10 in which the 
molecular graph obtained for MTX  is shown. Molecular graphs were analyzed for the 
different complexes studied here. We only show thatobtained for MTX  as an example in 
which the main interactions might be appreciated (Figure 10). 
 




Error (%)  
Theoretical Experimental 
7 (*) -0.50 -0.46 8.79 
14c -1.46 -1.80 18.88 
15c -1.57 -1.64 4.08 





The next step was to determine whether this model using the electron density as molecular 
descriptor can only discriminate between compounds with different affinities, or by otherwise 
it is also possible to distinguish between compounds that have similar affinities. To test the 
model, the three classical inhibitors were removed from the test group, resulting in just a very 
slightly diminution of the R2 (0.90). It should be noted that the R2 testing the model was 0.99 
showing that the model is able to maintain not only a high correlation value but also an 
excellent predictive power. This result is extremely important as it shows that this model 
using the ρ(r) as molecular descriptor can be used to predict the activity of compounds with 
similar affinities in this series. This result is hig ly satisfactory as it allows us to achieve the 























ACCEPTED MANUSCRIPTsimilar affinities and not only compounds with different affinities. An important aspect to 
note when we use this type of approach is that just one molecular descriptor has been used 
and therefore we can easily understand the physical-chemical behavior of the different L-R 
complexes. In this sense it is possible to determine which are those amino acids that might 
perform stabilizing or destabilizing interactions on the various complexes and what is more 
important is that such information can be obtained quantitatively. 
 
CONCLUSIONS 
There are many techniques and approaches to study the postdocking problem. While many of 
these techniques are able to distinguish between compounds that have high affinity with 
respect to those with low affinity for the receptor, unfortunately most of these techniques have 
failed when they have to distinguish between compounds with similar affinities. 
In this paper we have succeeded in what we fail in our previous report [5]. In this case we 
have been able to get an excellent correlation between the electronic densities obtained from a 
QTAIM study with the experimental data. It is important to note that through this study is 
possible to differentiate the L-R affinity even though the compounds possess similar 
affinities. Very important additional information obtained through this type of study is that it 
is possible to visualize which amino acids are involved in the interactions determining the 
different affinities of the ligands. Such information is crucial when we are interested in the 
design of new specific ligands. Some additional benefits that may be mentioned for this 
approach are: the technique is relatively simple, easy to interpret and not too demanding about 
the computing time. However, a somewhat limiting aspect of this type of study is that the 
QTAIM study is highly dependent on the optimized geom try and therefore the 
conformational variability can be a serious problem. In the particular case of DHFR this is not 
too problematic due to the structural characteristics of the active site of the enzyme. It is well 
known that the DHFR binding pocket is relatively narrow, with little space for the ligand and 
therefore does not lead to large conformational changes at least in comparison with others 
more flexible binding sites. These features of the active site have allowed that with care in the 
calculations (four conformations for each complex were considered), it is possible to obtain 
highly satisfactory results. Clearly, if the characteristics of the active site are different it is 
necessary to check whether this technique is effective exactly with this procedure or if it is 
necessary to consider more carefully the issue of con ormational variability of the various 
complexes.  
In summary, in this paper we have shown that the electron density obtained from a QTAIM 
analysis is an excellent descriptor of molecular interactions that stabilize and destabilize the 












ACCEPTED MANUSCRIPTpreparation of models which might allow to differentiate the affinity between ligands even 
when they show similar affinities. The possibility of using this postdocking technique on 
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Figure 1. Structural features of the compounds reported by Gangjee et al. (1-13) and Tosso et 
al. (14a and 15a). Each IC50 value is indicated in parenthesis. 
 
Figure 2. Surface of the active site of DHFR (light blue). MTX  (yellow sticks), NADP+ (grey 
sticks) and the protein (magenta ribbon) are also represented. Leu22 and Trp24 were not 
considered in the surface for clarify. 
 
Figure 3. Correlation obtained from LIE calculations. The x-axis denotes relative energies 
(∆∆G), and the y-axis denotes the inhibitory activity value of each compund (-log IC50). 
 
Figure 4. Correlation obtained from semi-empirical calculations. The x-axis denotes PM6 
relative energies, and the y-axis denotes the inhibitory activity value of each compund (-log 
IC50). 
 
Figure 5. Correlation obtained from ab initio calculations. The x-axis denotes ab initio 
(RHF/6-31G(d)) relative energies, and the y-axis denotes the inhibitory activity value of each 
compound (-log IC50). 
 
Figure 6. Correlation obtained from DFT calculations. The x-axis denotes DFT (PBE1PBE/6-
31G(d)) relative energies, and the y-axis denotes the inhibitory activity value of each 
compound (-log IC50). 
 
Figure 7. Charge density values for the total interactions of the Pyr ring system (orange 
stacked bars) and the C6 and/or N7 side chains (green stacked bars) for the inhibitors at the 
binding pocket. The repulsive short C-H··· -C contacts were not included. 
 
Figure 8. Schematic representation of each moiety of the diff rent inhibitors. The main ring 
(Pyr ring) of the compounds is indicated in orange.  
 
Figure 9. R2 values of each obtained correlation employing different number of residues. 
 
Figure 10. MTX (in orange sticks) at the DHFR binding site (in green sticks). Also the 












ACCEPTED MANUSCRIPTpaths connecting the nuclei and the red circles on them are the BCPs. Due to the complexity 
of the structure most of the interactions of water molecules are not shown. 
 

















The electronic density obtained from a QTAIM analysis used as molecular 
descriptor. A study performed in a new series of DHFR inhibitors 
 
Rodrigo D. Tosso, Marcela Vettorazzi, Sebastian A. Andujar, Lucas J. Gutierrez, Juan C. Garro, 
Emilio Angelina, Ricaurte Rodríguez, Fernando D. Suvire, Manuel Nogueras, Justo Cobo and Ricardo 
D. Enriz 
 
Departamento de Química, Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de 
San Luis, Chacabuco 915, 5700 San Luis, Argentina 
 
 
• A new series of guanine and imine derivatives has been synthesized. 
• The activities of the new compounds were evaluated gainst human DHFR. 
• MD simulations, QM calculations and QTAIM analysis were performed. 
• An excellent correlation between theoretical and experimental data was obtained. 
